Goldman Sachs raises Lazard stock price target on expense management

Goldman Sachs raised its price target for Lazard (NYSE:LAZ) to $35 from $32, maintaining a Sell rating. Lazard's Q3 2026 adjusted EPS of $0.36 missed estimates, with revenue 6% below expectations. Despite this, the company expects strong Financial Advisory performance and positive net organic flows in asset management. Goldman reduced its earnings estimates for 2026-2028 but increased its target P/E multiple.

Original reporting
Published Oct 22, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LAZ
Bearish
high confidence
Mentioned
$LAZ
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LAZBearishLow
01

Why it matters

Earnings miss and lowered guidance drive negative sentiment; the modest target raise is unlikely to offset the sell pressure.

02

Market read

The earnings shortfall and revised forecasts are the primary drivers of market reaction for Lazard.

03

What to watch

Potential upside from upcoming M&A activity and pipeline strength not fully reflected in the price target.

Relevance 7/10Novelty 6/10Timing: after-hours reaction

Background

Lazard reported Q3 2026 adjusted EPS of $0.36 versus expectations of $0.44, with revenue $814M versus $848.6M expected. Goldman cut its earnings forecasts for 2026‑2028 and raised the target price to $35 while maintaining a Sell rating.

Company-level read

Ticker impact

$LAZBearishHigh confidence
Context

Goldman Sachs raised Lazard's price target to $35 after the company's Q3 earnings miss and lowered earnings estimates.

Expected impact

downward pressure as the market prices in the earnings shortfall and sell rating.

Evidence & confidence

The earnings miss and reduced forecasts outweigh the modest target increase, likely prompting short-term sell-offs.

Market effects

Highlights pressure on financial advisory and asset‑management firms facing earnings volatility.

Limited to U.S. and European investors tracking Lazard.

Modest, confined to the investment banking sector.

Counterpoint

The higher target may signal undervaluation, offering a potential buying opportunity on dip.

Key entities

  • Lazard Ltd.

    Global financial advisory and asset management firm.

  • Goldman Sachs

    Investment bank that issued the new price target and revised forecasts.

Related articles

$LAZLow

Lazard Reports October 2026 Assets Under Management

Lazard (NYSE: LAZ) reported $282.4B in AUM for October 2026, down from $284B in September. The decline included market depreciation of $1.9B, FX depreciation of $1.4B, and net inflows of $1.7B. Lazard is a financial advisory and asset management firm listed on the NYSE.

$LAZHighAI 8/10

Lazard completes Campbell Lutyens acquisition, launches new unit

Lazard Inc. (NYSE:LAZ) completed its acquisition of Campbell Lutyens, launching Lazard CL, a private capital advisory unit. The deal, paid mostly in Lazard stock, combines their advisory operations. Lazard CL has 300+ professionals across 19 offices and has advised on over $1 trillion in capital. The company expects Lazard CL to generate $500M in revenue in 2027, boosting earnings.

$LAZMedAI 8/10

Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital

Lazard Inc. (NYSE: LAZ) completed its acquisition of Campbell Lutyens, launching Lazard CL, a global leader in private capital advisory. The deal, announced in April 2026, combines Lazard's and Campbell Lutyens' operations, creating a platform with 300 professionals and 19 offices worldwide. Lazard CL is expected to generate $500 million in revenue in 2027 and be accretive to earnings, according to the company.